California this year took the final step in opening Medi-Cal, its Medicaid program, to every eligible resident regardless of immigration status. It’s a significant expansion for an already massive safety net program.
EU Allocates €6.5M for Psychedelic Study
The TDR Three Key Takeaways: 1. The EU €6.5 million investment in the PsyPal trial marks its first foray into funding psychedelic therapy research, aiming
January 24, 2024